Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Post-Extubation Early Ventilation Recommended for Chronic Respiratory Disorder Patients

By HospiMedica International staff writers
Posted on 01 Sep 2009
A new study has found that early noninvasive ventilation (NVI) after extubation reduces mortality and lowers risk of respiratory failure in patients with chronic respiratory disorder.

Researchers from Hospital Clinic of Barcelona (Spain) conducted a randomized controlled study that enrolled 106 mechanically ventilated patients with chronic respiratory disorders and hypercapnia from three intensive-care units in Spain. More...
Following extubation, the patients received either NVI for 24 hours (54 patients) or conventional oxygen treatment (52). The primary endpoint was avoidance of respiratory failure within 72 hours after extubation.

The researchers found that those patients given early NVI after extubation had a lower risk of death and respiratory failure than those given normal oxygen therapy. NVI was associated with an 83% decreased risk of respiratory failure after extubation, a reduction independent from other potential confounding factors. Respiratory failure after extubation was less frequent in the patients that were assigned to NVI (15%) than in those allocated conventional oxygen therapy (48%); in patients with respiratory failure, NVI as rescue therapy avoided reintubation in 17 of 27 patients. Additionally, 90-day mortality was lower in the patients assigned to NVI (11%) than in those allocated to conventional oxygen (31%). The study was published early online in the August 12, 2009, edition of the Lancet.

"Early noninvasive ventilation after extubation diminished risk of respiratory failure and lowered 90-day mortality in patients with hypercapnia during a spontaneous breathing trial,” concluded lead author Miquel Ferrer, M.D., and colleagues of the thorax clinical unit. "Routine implementation of this strategy for management of mechanically ventilated patients with chronic respiratory disorders is advisable.”

NVI is the provision of ventilation support through the patient's upper airway using a mask or similar device. A slightly pressurized airflow is blown into the mask while breathing; the strength of the pressure varies during the breathing cycle. The airflow is strongest during inspiration, helping to take in as much air as possible; airflow pressure is lower during exhalation, but remains positive. This continual positive pressure helps to ‘splint' the airways open, enabling more air to get in and out of the lungs. The system is also known as BIPAP (bilevel positive airway pressure).

Related Links:

Hospital Clínic of Barcelona



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.